União Brasileira de Educação e Assistência - Hospital São Lucas da PUC - RS
Welcome,         Profile    Billing    Logout  
 0 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Caramori, Paulo Ricardo
ACTIV-4, NCT04505774 / 2020-004285-19: Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE

Completed
4
3591
Europe, US, RoW
theraputic heparin, unfractionated heparin, Enoxaparin, Dalteparin, Tinzaparin, Heparin, prophylactic heparin, enoxaparin, dalteparin, Fondparinux, P2Y12, Ticagrelor, Prasugrel, Clopidogrel, Crizanlizumab Injection, SGLT2 inhibitor, dapagliflozin, empagliflozin, canagliflozin, ertugliflozin
Matthew Neal MD, National Heart, Lung, and Blood Institute (NHLBI)
Covid19
08/23
01/24
NCT04591210: The COVID-RASi Trial (COVID-19)

Active, not recruiting
3
1155
Canada, RoW
Angiotensin converting enzyme inhibitor, Angiotensin II Receptor Blockers
Ottawa Heart Institute Research Corporation
COVID-19, Cardiovascular Diseases
12/24
12/25
NEOMINDSET, NCT04360720: PercutaNEOus Coronary Intervention Followed by Monotherapy INstead of Dual Antiplatelet Therapy in the SETting of Acute Coronary Syndromes: The NEO-MINDSET Trial

Recruiting
3
3400
RoW
Antiplatelet Monotherapy
Hospital Israelita Albert Einstein
Acute Coronary Syndrome
01/24
01/24
NCT06292013: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

Recruiting
3
12500
Europe, Canada, Japan, US, RoW
Lepodisiran Sodium, LY3819469, Placebo
Eli Lilly and Company
Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a)
03/29
03/29
NCT05180240 / 2021-006637-19: Impact of CardiolRx on Myocardial Recovery in Patients With Acute Myocarditis

Active, not recruiting
2
109
Europe, Canada, US, RoW
CardiolRx, Cannabidiol
Cardiol Therapeutics Inc., Cardiol Therapeutics Inc.
Acute Myocarditis
01/25
02/25

Download Options